Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Filings indexed 509 across all filing types
Latest filing 2022-10-30 Interim / Quarterly Rep…
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
Quarterly Activities Report 7 pages 444.6KB
Interim / Quarterly Report Classification · 95% confidence The document is titled as an ASX Announcement and provides a detailed quarterly activities report, cash flow report, and operations update for the quarter ended 30 September 2022. It includes financial data such as cash reserves, net cash used in operating activities, and expenditure breakdowns. It also discusses management and board changes, clinical development updates, regulatory interactions, and operational highlights. The presence of substantive financial data and operational analysis for a quarter indicates this is a comprehensive interim/quarterly report rather than a brief announcement or presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-10-30 English
Change in substantial holding 2 pages 187.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001 Section 671B. It details changes in voting power and shareholdings of a substantial holder, Cannvalate Pty Ltd, including dates and number of shares affected. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report, but a regulatory notification about shareholding changes.
2022-10-18 English
Section 708A Notice 1 page 150.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 10 October 2022 regarding a Section 708A notification under the Corporations Act 2001. It details the issue of 18,800,000 ordinary shares and the associated legal exemption for on-sale of securities without disclosure. The content is a regulatory compliance notice about a share issue, not a full financial report or detailed capital update. The document is short (1546 characters) and serves as a formal notification rather than a comprehensive report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2022-10-09 English
Final Director's Interest Notice 2 pages 260.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details the director's relevant interests in securities and notes the cessation of a director's role. This type of document is a report of personal share transactions or holdings by company directors, which fits the definition of 'Director's Dealing'. The document length is short and focused solely on director interests, with no financial statements or other report content. Therefore, it is classified as a Director's Dealing (DIRS).
2022-10-03 English
Initial Director's Interest Notice 2 pages 251.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including holdings and contracts, which is typical of a director's dealing or insider trading disclosure. The document is short (2223 characters) and focuses solely on the director's securities interests and related contracts. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or interests by company directors and executives. There is no indication of financial results, management changes, or other report types. Therefore, the correct classification is DIRS (Director's Dealing).
2022-10-03 English
Appendix 3B (updated) 54 pages 518.2KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard form used by entities listed on the Australian Securities Exchange (ASX) to announce a proposed issue of securities. The text includes detailed sections about the entity, the type of securities issue (placement, bonus issue, entitlement offer, etc.), and conditions related to the issue. It is clearly an announcement related to capital raising activities, specifically the proposed issue of securities. There is no indication that this is a full financial report, audit report, or earnings release. The document is not a report publication announcement but the actual announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2022-10-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.